Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Sep-24 6:27 PM View:  | Sandison Taylor Chief Medical Officer | Cidara Therapeutics, Inc. (CDTX) | 11-Sep-24 | Private Sale | 924 | $11.64 | $10,752.30 | (4%) 23.99K to 23.07K | |
| 13-Sep-24 6:26 PM View: | Tari Leslie Chief Scientific Officer | Cidara Therapeutics, Inc. (CDTX) | 11-Sep-24 | Private Sale | 909 | $11.64 | $10,580.10 | (5%) 18.77K to 17.86K | |
| 22-Jul-24 5:11 PM View: | Ra Capital Management, LLC Director | Cidara Therapeutics, Inc. (CDTX) | 19-Jul-24 | Conversion | 703,080 | -- | -- | 100% 0 to 703.08K | |
| 11-Jun-24 6:26 PM View: | Stein Jeffrey President & CEO Director | Cidara Therapeutics, Inc. (CDTX) | 07-Jun-24 | Purchase | 8,000 | $13.21 | $105,680.00 | 10% 76.56K to 84.56K | |
| 20-Mar-24 6:48 PM View: | Shah Preetam CFO & CBO | Cidara Therapeutics, Inc. (CDTX) | 15-Mar-24 | Grant | 108,750 | -- | -- | 48% 227.21K to 335.96K | |
| 20-Mar-24 6:47 PM View: | Sandison Taylor Chief Medical Officer | Cidara Therapeutics, Inc. (CDTX) | 15-Mar-24 | Grant | 128,750 | -- | -- | 37% 347.1K to 475.85K | |
| 20-Mar-24 6:48 PM View: | Ward Shane COO & CLO | Cidara Therapeutics, Inc. (CDTX) | 15-Mar-24 | Grant | 120,000 | -- | -- | 60% 198.77K to 318.77K | |
| 20-Mar-24 6:47 PM View: | Tari Leslie Chief Scientific Officer | Cidara Therapeutics, Inc. (CDTX) | 15-Mar-24 | Grant | 111,250 | -- | -- | 43% 260.17K to 371.42K | |
| 12-Mar-24 9:46 PM View: | Ward Shane COO & CLO | Cidara Therapeutics, Inc. (CDTX) | 11-Mar-24 | Sale | 20,473 | $0.67 | $13,712.80 | (9%) 219.24K to 198.77K | |
| 12-Mar-24 9:48 PM View: | Tari Leslie Chief Scientific Officer | Cidara Therapeutics, Inc. (CDTX) | 11-Mar-24 | Sale | 21,029 | $0.67 | $14,085.20 | (7%) 281.19K to 260.17K | |
| 12-Mar-24 9:48 PM View: | Stein Jeffrey President & CEO Director | Cidara Therapeutics, Inc. (CDTX) | 11-Mar-24 | Payment of Exercise | 56,692 | $0.69 | $39,117.50 | (4%) 1.58M to 1.53M | |
| 12-Mar-24 9:45 PM View: | Shah Preetam CFO & CBO | Cidara Therapeutics, Inc. (CDTX) | 11-Mar-24 | Sale | 18,931 | $0.67 | $12,680.00 | (8%) 246.14K to 227.21K | |
| 12-Mar-24 9:47 PM View: | Sandison Taylor Chief Medical Officer | Cidara Therapeutics, Inc. (CDTX) | 11-Mar-24 | Sale | 20,662 | $0.67 | $13,839.40 | (6%) 367.76K to 347.1K | |
| 13-Sep-23 4:22 PM View: | Sandison Taylor Chief Medical Officer | Cidara Therapeutics, Inc. (CDTX) | 11-Sep-23 | Market Sale | 18,793 | $0.95 | $17,810.10 | (5%) 382.55K to 363.76K | (11%) |
| 13-Sep-23 4:24 PM View: | Tari Leslie Chief Scientific Officer | Cidara Therapeutics, Inc. (CDTX) | 11-Sep-23 | Market Sale | 18,469 | $0.95 | $17,508.60 | (6%) 295.66K to 277.19K | (11%) |
| 14-Aug-23 7:40 PM View: | Tari Leslie Chief Scientific Officer | Cidara Therapeutics, Inc. (CDTX) | 14-Aug-23 | Private Purchase | 10,000 | $0.97 | $9,700.00 | 4% 285.66K to 295.66K | |
| 08-Aug-23 6:04 PM View: | Stein Jeffrey President & CEO Director | Cidara Therapeutics, Inc. (CDTX) | 08-Aug-23 | Private Purchase | 50,000 | $0.96 | $47,885.00 | 3% 1.53M to 1.58M | |
| 29-Mar-23 5:32 PM View: | Ward Shane COO & CLO | Cidara Therapeutics, Inc. (CDTX) | 27-Mar-23 | Grant | 126,667 | -- | -- | 150% 84.58K to 211.24K | |
| 29-Mar-23 5:26 PM View: | Tari Leslie Chief Scientific Officer | Cidara Therapeutics, Inc. (CDTX) | 27-Mar-23 | Grant | 90,000 | -- | -- | 47% 191.66K to 281.66K | |
| 29-Mar-23 5:30 PM View: | Stein Jeffrey President & CEO Director | Cidara Therapeutics, Inc. (CDTX) | 27-Mar-23 | Grant | 271,750 | -- | -- | 22% 1.25M to 1.53M | |
| 29-Mar-23 5:28 PM View: | Sandison Taylor Chief Medical Officer | Cidara Therapeutics, Inc. (CDTX) | 27-Mar-23 | Grant | 90,000 | -- | -- | 31% 288.55K to 378.55K | |
| 29-Mar-23 5:24 PM View: | Shah Preetam CFO & CBO | Cidara Therapeutics, Inc. (CDTX) | 27-Mar-23 | Grant | 90,000 | -- | -- | 61% 148.14K to 238.14K | |
| 27-Mar-23 7:03 PM View: | Stein Jeffrey President & CEO Director | Cidara Therapeutics, Inc. (CDTX) | 27-Mar-23 | Market Purchase | 50,000 | $1.04 | $51,855.00 | 4% 1.2M to 1.25M | 1% |
| 13-Mar-23 9:20 PM View: | Shah Preetam CFO & CBO | Cidara Therapeutics, Inc. (CDTX) | 13-Mar-23 | Private Sale | 6,648 | $1.53 | $10,171.40 | (4%) 154.79K to 148.14K | |
| 13-Mar-23 9:21 PM View: | Tari Leslie Chief Scientific Officer | Cidara Therapeutics, Inc. (CDTX) | 13-Mar-23 | Private Sale | 7,562 | $1.53 | $11,569.90 | (4%) 199.22K to 191.66K | |
| 13-Mar-23 9:21 PM View: | Ward Shane COO & CLO | Cidara Therapeutics, Inc. (CDTX) | 13-Mar-23 | Private Sale | 4,329 | $1.53 | $6,623.37 | (5%) 88.91K to 84.58K | |
| 13-Mar-23 9:19 PM View: | Sandison Taylor Chief Medical Officer | Cidara Therapeutics, Inc. (CDTX) | 13-Mar-23 | Private Sale | 7,203 | $1.53 | $11,020.60 | (2%) 295.75K to 288.55K | |
| 27-Jan-23 4:33 PM View: | Tari Leslie Chief Scientific Officer | Cidara Therapeutics, Inc. (CDTX) | 12-Jan-23 | Private Sale | 11,814 | $1.20 | $14,176.80 | (6%) 211.04K to 199.22K | |
| 19-Sep-22 8:28 PM View: | Shah Preetam CFO & CBO | Cidara Therapeutics, Inc. (CDTX) | 19-Sep-22 | Option Sale | 15,642 | $0.77 | $12,035.00 | (9%) 166.43K to 150.79K | |
| 19-Sep-22 8:28 PM View: | Shah Preetam CFO & CBO | Cidara Therapeutics, Inc. (CDTX) | 15-Sep-22 | Option Exercise | 50,000 | -- | -- | 43% 116.43K to 166.43K | |
| 13-Sep-22 6:40 PM View: | Daruwala Paul Chief Operating Officer | Cidara Therapeutics, Inc. (CDTX) | 12-Sep-22 | Sale | 16,199 | $0.68 | $11,094.70 | (7%) 237.3K to 221.1K | |
| 13-Sep-22 6:51 PM View: | Sandison Taylor Chief Medical Officer | Cidara Therapeutics, Inc. (CDTX) | 12-Sep-22 | Sale | 18,478 | $0.68 | $12,655.60 | (6%) 310.23K to 291.75K | |
| 13-Sep-22 6:48 PM View: | Tari Leslie Chief Scientific Officer | Cidara Therapeutics, Inc. (CDTX) | 12-Sep-22 | Sale | 18,159 | $0.68 | $12,437.10 | (8%) 225.2K to 207.04K | |
| 04-Apr-22 5:09 PM View: | Stein Jeffrey President & CEO Director | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-22 | Payment of Exercise | 140,985 | $0.83 | $117,018.00 | (11%) 1.34M to 1.2M | |
| 04-Apr-22 5:23 PM View: | Johnson Brady Vice President, Finance | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-22 | Grant | 10,000 | -- | -- | 20% 49.37K to 59.37K | |
| 04-Apr-22 5:12 PM View: | Ward Shane CHIEF LEGAL OFFICER | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-22 | Grant | 104,027 | -- | -- | 100% 0 to 104.03K | |
| 04-Apr-22 5:21 PM View: | Shah Preetam CFO & CBO | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-22 | Payment of Exercise | 24,820 | $0.83 | $20,600.60 | (18%) 137.25K to 112.43K | |
| 04-Apr-22 5:16 PM View: | Sandison Taylor Chief Medical Officer | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-22 | Grant | 50,000 | -- | -- | 20% 256.23K to 306.23K | |
| 04-Apr-22 5:04 PM View: | Daruwala Paul Chief Operating Officer | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-22 | Grant | 50,000 | -- | -- | 27% 187.3K to 237.3K | |
| 04-Apr-22 5:12 PM View: | Ward Shane CHIEF LEGAL OFFICER | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-22 | Payment of Exercise | 23,122 | $0.83 | $19,191.30 | (22%) 104.03K to 80.91K | |
| 04-Apr-22 5:07 PM View: | Tari Leslie Chief Scientific Officer | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-22 | Grant | 52,500 | -- | -- | 31% 168.7K to 221.2K | |
| 04-Apr-22 5:09 PM View: | Stein Jeffrey President & CEO Director | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-22 | Grant | 573,742 | -- | -- | 75% 763.49K to 1.34M | |
| 04-Apr-22 5:21 PM View: | Shah Preetam CFO & CBO | Cidara Therapeutics, Inc. (CDTX) | 31-Mar-22 | Grant | 117,251 | -- | -- | 586% 20.0K to 137.25K | |
| 23-Mar-22 6:11 PM View: | Johnson Brady Vice President, Finance | Cidara Therapeutics, Inc. (CDTX) | 21-Mar-22 | Sale | 654 | $0.81 | $529.74 | (1%) 50.02K to 49.37K | |
| 11-Mar-22 8:29 PM View: | Johnson Brady Vice President, Finance | Cidara Therapeutics, Inc. (CDTX) | 11-Mar-22 | Sale | 945 | $0.71 | $670.95 | (2%) 50.97K to 50.02K | |
| 07-Jan-22 8:23 PM View: | Johnson Brady Vice President, Finance | Cidara Therapeutics, Inc. (CDTX) | 05-Jan-22 | Market Sale | 154 | $1.25 | $192.50 | (< 1%) 51.12K to 50.97K | |
| 07-Jan-22 8:20 PM View: | Tari Leslie Chief Scientific Officer | Cidara Therapeutics, Inc. (CDTX) | 05-Jan-22 | Market Option Sale | 1,252 | $1.25 | $1,565.00 | (< 1%) 169.95K to 168.7K | |
| 07-Jan-22 8:23 PM View: | Johnson Brady Vice President, Finance | Cidara Therapeutics, Inc. (CDTX) | 05-Jan-22 | Market Option Sale | 262 | $1.25 | $327.50 | (< 1%) 51.38K to 51.12K | |
| 07-Jan-22 8:26 PM View: | Daruwala Paul Chief Operating Officer | Cidara Therapeutics, Inc. (CDTX) | 05-Jan-22 | Market Option Sale | 5,133 | $1.25 | $6,416.25 | (3%) 192.43K to 187.3K | |
| 07-Jan-22 8:20 PM View: | Tari Leslie Chief Scientific Officer | Cidara Therapeutics, Inc. (CDTX) | 29-Dec-21 | Option Exercise | 2,101 | -- | -- | 1% 167.85K to 169.95K |
